x
Breaking News
More () »

Former executive at Arizona-based pharmaceutical company sentenced to 5 1/2 years for pushing opioid

John Kapoor, the 76-year-old former chairman of Insys Therapeutics, was sentenced Thursday in federal court in Boston.
Credit: AP
Insys Therapeutics founder John Kapoor arrives for sentencing at federal court on Thursday, Jan. 23, 2020, in Boston. Kapoor was convicted in a bribery and kickback scheme that prosecutors said helped fuel the opioid crisis. He and others in the company were accused of paying millions of dollars in bribes to doctors across the nation to prescribe the company's highly addictive fentanyl spray, known as Subsys. (AP Photo/Charles Krupa)

The founder of an Arizona pharmaceutical company has been sentenced to 5 1/2 years in prison for his role in a bribery and kickback scheme that prosecutors said helped fuel the opioid crisis. 

John Kapoor, the 76-year-old former chairman of Insys Therapeutics, was sentenced Thursday in federal court in Boston. 

Credit: AP
Insys Therapeutics founder John Kapoor arrives for sentencing at federal court on Thursday, Jan. 23, 2020, in Boston. Kapoor was convicted in a bribery and kickback scheme that prosecutors said helped fuel the opioid crisis. He and others in the company were accused of paying millions of dollars in bribes to doctors across the nation to prescribe the company's highly addictive fentanyl spray, known as Subsys. (AP Photo/Charles Krupa)

PREVIOUSLY: Executive of Chandler-based company guilty of bribing doctors to push opioid

Kapoor and others were accused of paying millions of dollars in bribes to doctors across the nation to prescribe the company’s highly addictive fentanyl spray, known as Subsys. 

The case is considered the first that sought to hold an opioid maker criminally liable for the drug crisis, which has claimed nearly 400,000 lives over the last two decades.

MORE RELATED STORIES:

Chandler-based Insys Therapeutics unit pleads guilty to opioid bribery scheme

Opioid maker agrees to pay $225M to settle federal probes

Before You Leave, Check This Out